Trial intelligence / Profile preview

Phase I multiple-dose study of T-4288 (solithromycin) in healthy adults

jRCT2080222387Phase 1

Sponsor
Fujifilm
Start
Feb 2014
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in bacterial disease comparing T-4288 (solithromycin) with Placebo (2 arms).

02

Drugs

solithromycin
03

Conditions

bacterial disease

Beyond the preview

Go deeper on jRCT2080222387.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080222387.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call